Harnessing the potential synergy of combining radiation therapy and immunotherapy for thoracic malignancies

Affiliations

¹ Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, USA. (Email: charlessimone@umm.edu).
² Department of Radiation Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA. (Email: Abigail.berman@uphs.upenn.edu).
³ Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA. (Email: jabbousk@cinj.rutgers.edu).

Charles B Simone 2nd et al. Transl Lung Cancer Res. 2017 Apr.

. 2017 Apr;6(2):109-112.

doi: 10.21037/tlcr.2017.04.05.

¹ Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, USA. (Email: charlessimone@umm.edu).
² Department of Radiation Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA. (Email: Abigail.berman@uphs.upenn.edu).
³ Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA. (Email: jabbousk@cinj.rutgers.edu).

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

1. Howlader N, Noone AM, Krapcho M, et al. editors. SEER Cancer Statistics Review, 1975-2013, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2013/, based on November 2015 SEER data submission, posted to the SEER web site, April 2016.
1. Goldstraw P, Chansky K, Crowley J, et al. The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer. J Thorac Oncol 2016;11:39-51. 10.1016/j.jtho.2015.09.009 - DOI - PubMed
1. Vogelzang NJ, Rusthoven JJ, Symanowski J, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003;21:2636-44. 10.1200/JCO.2003.11.136 - DOI - PubMed
1. Zalcman G, Mazieres J, Margery J, et al. Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial. Lancet 2016;387:1405-14. 10.1016/S0140-6736(15)01238-6 - DOI - PubMed
1. Jackson MW, Palma DA, Camidge DR, et al. The Impact of Postoperative Radiotherapy for Thymoma and Thymic Carcinoma. J Thorac Oncol 2017;12:734-44. 10.1016/j.jtho.2017.01.002 - DOI - PubMed